stoxline Quote Chart Rank Option Currency Glossary
Anebulo Pharmaceuticals, Inc. (ANEB)
2.27  -0.03 (-1.3%)    07-11 16:00
Open: 2.31
High: 2.5699
Volume: 9,922
Pre. Close: 2.3
Low: 2.27
Market Cap: 59(M)
Technical analysis
2024-07-12 1:18:55 PM
Short term     
Mid term     
Targets 6-month :  2.97 1-year :  3.45
Resists First :  2.55 Second :  2.96
Pivot price 2.53
Supports First :  1.88 Second :  1.57
MAs MA(5) :  2.45 MA(20) :  2.42
MA(100) :  2.57 MA(250) :  2.56
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  42.2 D(3) :  53.1
RSI RSI(14): 45.2
52-week High :  4.05 Low :  1.62
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ANEB ] has closed above bottom band by 21.5%. Bollinger Bands are 30.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.51 - 2.53 2.53 - 2.54
Low: 2.27 - 2.29 2.29 - 2.3
Close: 2.3 - 2.32 2.32 - 2.34
Company Description

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.

Headline News

Mon, 01 Jul 2024
Financial Contrast: Anebulo Pharmaceuticals (NASDAQ:ANEB) vs. IO Biotech (NASDAQ:IOBT) - Defense World

Sat, 22 Jun 2024
Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation - Simply Wall St

Wed, 15 May 2024
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates - Yahoo Finance

Mon, 15 Apr 2024
We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Needs To Drive Business Growth Carefully - Yahoo Finance

Fri, 06 Oct 2023
Anebulo Pharmaceuticals Announces New CEO - Business Wire

Sat, 26 Aug 2023
Cannabinoid antagonist ANEB-001 could address THC overdose - Drug Discovery & Development

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 26 (M)
Shares Float 4 (M)
Held by Insiders 65.3 (%)
Held by Institutions 28.1 (%)
Shares Short 11 (K)
Shares Short P.Month 6 (K)
Stock Financials
EPS -0.38
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.18
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -58 %
Return on Equity (ttm) -104.3 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -9 (M)
Levered Free Cash Flow -6 (M)
Stock Valuations
PE Ratio -6.14
PEG Ratio 0
Price to Book value 11.94
Price to Sales 0
Price to Cash Flow -6.63
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android